| Literature DB >> 36246331 |
Jian-Ming Li1,2,3, Lian-Min Li1,2,3, Jun-Feng Shi1,2,3, Ting Li1,2,3, Qi Wang1,2,3, Qing-Xia Ma1,2,3, Wei Zheng1,2,3, Hai-Feng Feng4, Fei Liu1,3, Rui Du1,3,5.
Abstract
Leptospirosis is an acute infectious disease caused by pathogenic bacteria from the genus Leptospira. The disease is widely distributed throughout China, causing harm to human and animal health. Murine may naturally carry a variety of pathogenic Leptospira, thus being important sources of infection by humans and livestock. The aim of this study was to assess and analyse the prevalence of Leptospira and its risk factors in murine. We collected 46 publications published between inception and 2022 through China Knowledge Network (CNKI), VIP Chinese Journal Database, Wanfang Database, PubMed, and ScienceDirect. In these studies, a total of 54,051 murine in 5 regions of China were investigated, and the prevalence of leptospirosis ranged from 1.11 to 35.29%. The prevalence of murine leptospirosis in south China was the highest, at 20.13%, and the lowest in northeast China, at 1.11% (P < 0.05). The prevalence of leptospirosis in male murine was 21.38%, which was significantly higher than that in females (17.07%; P < 0.05). Results according to detection method subgroup showed that the prevalence from serological testing was 15.94%, which was significantly higher than that of etiology and molecular biology methods (P < 0.01). In the sample subgroup, the positive rate of serum samples was 15.30%, which was significantly higher than that of tissue samples, at 7.97%. In addition, the influence of different geographical factors on prevalence was analyzed, indicating that the Yangtze River Basin was a high-incidence area for leptospirosis. The study showed that Leptospira were ubiquitous throughout the country, and factors such as environment, temperature and landform affect the murine distribution and their bacteria carrying rate. We suggest strengthening the continuous monitoring of leptospirosis and taking effective and comprehensive measures such as reducing water contact, vaccinating in high-incidence seasons, and avoiding human contamination caused by water pollution and contact with infected murine.Entities:
Keywords: China; Leptospira; Mice; epidemiology; meta-analysis; murine; rat
Year: 2022 PMID: 36246331 PMCID: PMC9557099 DOI: 10.3389/fvets.2022.944282
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Normal distribution test and conversion of the normal distribution.
|
|
| |
|---|---|---|
| PRAW | 0.89152 | 0.000451 |
| PLN | 0.9567 | 0.08531 |
| PLOGIT | 0.96938 | 0.2627 |
| PAS | 0.95841 | 0.09942 |
| PFT | 0.95722 | 0.08933 |
W, weight; PRAW, original rate; PLN, logarithmic conversion; PLOGIT, logit transformation; PAS, arcsine transformation; PFT, double-arcsine transformation.
Figure 1Flow chart showing the study selection process for inclusion and exclusion studies.
Figure 2Forest plot of the prevalence of Leptospira in murine of China. “Study” represents the included studies; “Events” is the number of positive cases of Leptospira murine; “Total” is the total number of samples in each group; “Proportion” represents the prevalence, “CI” represents the confidence interval, “Weight” is the representative weight in the fixed and random models. The gray diamond at the bottom represents the total prevalence, the long vertical dotted line in the middle represents the meta-analysis results, and the intersection with the horizontal axis is the total OR value of 0.09, the short horizontal line represents the confidence interval of the study, the position of the short vertical line represents the OR value of each study, and the size of the short vertical line represents the weight.
Figure 3Funnel plot with pseudo 95% confidence interval limits for the examination of publication bias. The horizontal axis represents effect size, which is a measure of prevalence estimates (double arcsine transform). The vertical axis represents the transformed standard error. The gray origin represents the original study. The vertical line in the middle represents the combined effect (or main effect), and the slashed area on both sides of the vertical line represents the 95% confidence interval of the combined effect at different standard error scales. Since the slashes on both sides are not strictly 95% confidence intervals, they are called “pseudo 95% confidence limits”.
Figure 4Egger's test for publication bias. Egger's test builds a simple linear regression model with the standardized effect estimator as the dependent variable and the precision of the effect estimator (the inverse of the standard error) as the independent variable. Circles represent each included study.
Figure 5Trim-and-fill analysis. The vertical axis is the standard error, the horizontal axis is the Freeman-Tukey double Arcsine Transformed Proportion, the black dot represents the included studies, and the white dot represents the virtual studies.
Figure 6Sensitivity analysis. “Study” represents omitting study; “Proportion” represents pooled prevalence. The gray diamond at the bottom represents the total prevalence, the short horizontal line represents the confidence interval for the study. The short vertical line corresponding to each study represents the combined effect of the remaining studies after deleting the study, and the size of the gray square represents the size of the confidence interval.
Included studies of leptospirosis in murine.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| |||||
| Wang et al. ( | Hubei | Etiological testing | 21/240 | 4 | High |
| Cheng et al. ( | Hubei | Etiological testing | 27/2,012 | 4 | High |
| Liu et al. ( | Hunan | Etiological testing | 44/434 | 4 | High |
| Liu et al. ( | Hunan | Etiological testing | 10/573 | 4 | High |
| Liu ( | Hubei | Etiological testing | 42/232 | 4 | High |
| Xiao et al. ( | Hunan | Etiological testing | 41/267 | 4 | High |
| Chen ( | Hubei | Etiological testing | 74/374 | 4 | High |
| Liu et al. ( | Hunan | Etiological testing | 6/333 | 4 | High |
| Wang et al. ( | Henan | Etiological testing | 19/526 | 4 | High |
| Jiang ( | Hunan | Etiological testing | 150/1,103 | 4 | High |
| Cheng et al. ( | Hubei | Etiological testing | 186/1,319 | 3 | Middle |
| Wu et al. ( | Hubei | Etiological testing | 11/166 | 3 | Middle |
|
| |||||
| Jiang ( | Jiangxi | Etiological testing/Serological testing | 1/19 | 4 | High |
| Xu et al. ( | Zhejiang | Etiological testing | 33/107 | 4 | High |
| Xu and Zhang ( | Zhejiang | Etiological testing/Serological testing | 22/259 | 4 | High |
| Chen and Zhang ( | Zhejiang | Etiological testing | 393/2,121 | 2 | Middle |
| Chen et al. ( | Zhejiang | Serological testing | 18/91 | 3 | Middle |
| Zhang ( | Zhejiang | Etiological testing | 589/3,064 | 3 | Middle |
| Tao et al. ( | Jiangxi | Etiological testing | 300/2,240 | 4 | High |
| Zhao et al. ( | Zhejiang | Nucleic acid testing | 18/147 | 5 | High |
| Zhang et al. ( | Zhejiang | Serological testing | 18/397 | 4 | High |
| Xu et al. ( | Fujian | Serological testing | 195/733 | 4 | High |
| Zhang et al. ( | Jiangxi | Etiological testing | 64/1,404 | 5 | High |
| Hua et al. ( | Anhui | Etiological testing | 30/194 | 4 | High |
| Zhuang et al. ( | Fujian | Etiological testing | 1/59 | 3 | Middle |
| Chai et al. ( | Fujian | Nucleic acid testing | 29/677 | 4 | High |
| Zhou et al. ( | Fujian | Nucleic acid testing | 14/270 | 5 | High |
| Wei et al. ( | Zhejiang | Etiological testing | 5/100 | 4 | High |
| Huang ( | Fujian | Nucleic acid testing | 4/140 | 4 | High |
| Yang and Cai ( | Fujian | Serological testing | 1/26 | 4 | High |
|
| |||||
| Li et al. ( | Heilongjiang | UN | 2/77 | 4 | High |
| Liang et al. ( | Heilongjiang | UN | 11/1,025 | 3 | Middle |
|
| |||||
| Yang et al. ( | Guangdong | Nucleic acid testing | 45/400 | 4 | High |
| Ye et al. ( | Guangxi | Nucleic acid testing | 6/17 | 5 | High |
| Deng et al. ( | Guangdong | Serological testing | 174/724 | 4 | High |
|
| |||||
| Zhang et al. ( | Guizhou | Etiological testing | 1/174 | 4 | High |
| Zhang et al. ( | Sichuan | Etiological testing | 2/189 | 5 | High |
| Zhang et al. ( | Sichuan | Etiological testing | 120/2,633 | 5 | High |
| Li et al. ( | Guangzhou | Etiological testing | 2361/20,517 | 3 | Middle |
| Ou et al. ( | Sichuan | Etiological testing | 57/408 | 4 | High |
| Yang et al. ( | Guizhou | Etiological testing | 384/8,335 | 5 | High |
| Wei et al. ( | Sichuan | Etiological testing | 62/526 | 4 | High |
| Zhou et al. ( | Guizhou | Nucleic acid testing | 13/46 | 5 | High |
| Bai et al. ( | Guizhou | Etiological testing | 1/131 | 4 | High |
| Sun et al. ( | Yunnan | Nucleic acid testing | 7/71 | 4 | High |
| Li et al. ( | Guizhou | Etiological testing | 4/118 | 5 | High |
Figure 7Map of Leptospira in murine in China. Different saturations in the HSB slider represent different infection rates.
Pooled prevalence of leptospirosis infection by Leptospira classification.
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||
| 47.88% | |||||||||
| 1 | 620 | 1 | 0.16% | 0.00–0.69 | 0.00 | – | – | ||
| 1 | 1,012 | 4 | 0.40% | 0.08–0.90 | 0.00 | – | – | ||
| 1 | 1,404 | 1 | 0.07% | 0.00–0.31 | 0.00 | – | – | ||
| 4 | 3,746 | 43 | 0.92% | 0.43–1.56 | 5.29 | 0.15 | 43.3% | ||
| 16 | 14,198 | 1,030 | 7.05% | 4.32–10.37 | 685.56 | <0.01 | 97.8% | ||
| 4 | 3,942 | 9 | 0.12% | 0.00–0.91 | 19.92 | <0.01 | 84.9% | ||
| 2 | 3,275 | 2 | 0.05% | 0.00–0.18 | 0.44 | 0.51 | 0.0% | ||
| 3 | 3,030 | 7 | 0.36% | 0.00–1.39 | 11.30 | <0.01 | 82.3% | ||
| 3 | 3,322 | 2 | 0.00% | 0.00–0.11 | 4.63 | 0.1 | 56.8% | ||
| 1 | 333 | 1 | 0.30% | 0.00–1.29 | 0.00 | – | – | ||
| 8 | 10,606 | 767 | 4.73% | 2.29–7.97 | 685.56 | <0.01 | 97.8% | ||
| Total | 44 | 45,488 | 1,867 | 8.70% | 6.93–10.64 | 2011.73 | 0 | 97.8% | |
CI, confidence interval.
χ2 and I2, two heterogeneity evaluation indicators, heterogeneity was predicted using I2 and Cochrane Q statistics (expressed as χ2 and P-values), with an I2 value of 25% corresponding to low heterogeneity, 50% to moderate heterogeneity and 75% to high heterogeneity.
R2, explain the magnitude of heterogeneity.
The Leptospira named according to Adler's reference books and revisions.
Pooled prevalence of leptospirosis infection in different murine species.
|
|
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||
| 29.85% | |||||||||
|
|
| 27 | 29,562 | 3,646 | 10.13% (7.39–13.19) | 898.17 | <0.01 | 97.1% | |
|
| 2 | 111 | 0 | 0.00% (0.00–0.00) | 0.71 | 0.40 | 0.0% | ||
|
|
|
|
|
|
|
|
| ||
|
|
| 2 | 65 | 15 | 22.63% (9.95–38.31) | 1.88 | 0.17 | 46.9% | |
|
|
| 5 | 131 | 27 | 12.75% (0.01–36.06) | 19.36 | <0.01 | 79.3% | |
|
|
| 24 | 2,803 | 85 | 1.82% (0.41–3.87) | 115.42 | <0.01 | 80.1% | |
|
|
| 3 | 153 | 4 | 1.85% (0.04–5.22) | 1.23 | 0.54 | 0.0% | |
|
| 2 | 754 | 7 | 0.62% (0.00–1.93) | 1.15 | 0.28 | 13.2% | ||
|
| 4 | 330 | 35 | 4.76% (5.9–8.8) | 7.21 | 0.07 | 58.4% | ||
|
| 6 | 534 | 10 | 0.00% (0.00–1.58) | 7.09 | 0.21 | 29.5% | ||
|
|
|
|
|
|
|
|
| ||
|
|
| 2 | 13 | 5 | 29.04% (0.00–76.60) | 1.56 | 0.21 | 35.9% | |
|
| 28 | 2,444 | 267 | 5.12% (1.84–9.44) | 265.19 | <0.01 | 89.8% | ||
|
| 20 | 5,792 | 873 | 11.95% (8.20–16.20) | 226.30 | <0.01 | 91.6% | ||
|
| 5 | 979 | 37 | 10.30% (0.00–4.56) | 12.20 | 0.02 | 67.2% | ||
|
| 35 | 7,442 | 467 | 4.17% (1.81–7.17) | 664.84 | <0.01 | 94.9% | ||
|
|
|
|
|
|
|
|
| ||
CI, confidence interval.
χ2 and I2, two heterogeneity evaluation indicators, heterogeneity was predicted using I2 and Cochrane Q statistics (expressed as χ2 and P-values), with an I2 value of 25% corresponding to low heterogeneity, 50% to moderate heterogeneity and 75% to high heterogeneity.
R2, explain the magnitude of heterogeneity.
Total, the pooled prevalence of Leptospira in murine gens as a subgroup.
Pooled prevalence of leptospirosis infection in murine in China.
|
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||||
| Regions | 0.0126 | 0.174 (0.038–0.311) | ||||||||
| Central China | 12 | 6,579 | 631 | 8.60% (5.15–12.81) | 330.09 | < 0.01 | 96.7% | |||
| Eastern China | 18 | 12,076 | 1,736 | 10.16% (6.96–13.87) | 553.96 | < 0.01 | 96.9% | |||
| Northeastern China | 2 | 1,107 | 13 | 1.11% (0.18–2.61) | 1.39 | 0.24 | 28.2% | |||
| Southern China | 3 | 1,141 | 225 | 20.13% (9.36–33.51) | 32.08 | <0.01 | 93.8% | |||
| Southwestern China | 11 | 33,148 | 3,012 | 6.28% (3.73–9.40) | 594.64 | <0.01 | 98.3% | |||
| Provinces | 0.0214 | 0.0946 (0.014–0.175) | ||||||||
| Anhui | 1 | 194 | 30 | 15.46% (10.69- 20.92) | 0.00 | – | – | |||
| Fujian | 6 | 1,905 | 244 | 6.25% (0.58- 16.36) | 201.70 | <0.01 | 97.5% | |||
| Guangdong | 3 | 21,641 | 2,580 | 15.17% (8.27–23.68) | 77.85 | <0.01 | 97.4% | |||
| Guangxi | 1 | 17 | 6 | 35.29% (14.00–59.80) | 0.00 | – | – | |||
| Guizhou | 5 | 8,804 | 403 | 4.29% (1.10–9.16) | 40.06 | <0.01 | 90.0% | |||
| Henan | 1 | 526 | 19 | 3.61% (2.17–5.39) | 0.00 | – | – | |||
| Heilongjiang | 2 | 1,107 | 13 | 1.11% (0.18- 2.61) | 1.39 | 0.24 | 28.2% | |||
| Hubei | 6 | 3,343 | 361 | 10.81% (5.14–18.19) | 165.32 | <0.01 | 97.0% | |||
| Hunan | 5 | 2,710 | 251 | 7.36% (2.51–14.42) | 135.23 | <0.01 | 97.0% | |||
| Jiangxi | 3 | 3,691 | 366 | 7.23% (1.8–15.63) | 88.61 | <0.01 | 97.7% | |||
| Sichuan | 4 | 3,756 | 241 | 6.92% (2.59–13.08) | 77.59 | <0.01 | 96.1% | |||
| Yunnan | 1 | 71 | 7 | 9.86% (3.84–18.04) | 0.00 | – | – | |||
| Zhejiang | 8 | 6,286 | 1,096 | 13.70% (9.51–18.51) | 128.15 | <0.01 | 94.5% | |||
| Sampling year | 0.8036 | 0.011 (−0.077–0.099) | ||||||||
| 1960 to 2009 | 25 | 24,908 | 2,308 | 8.18% (5.69–11.07) | 1,207.41 | <0.01 | 98.0% | |||
| 2010 to 2020 | 13 | 5,156 | 383 | 7.52% (3.54–12.71) | 391.33 | <0.01 | 96.9% | |||
| Detection methods | 0.0065 | 0.124 (0.035–0.213) | ||||||||
| Aetiological testing | 31 | 49,177 | 5,061 | 8.24% (6.34–10.34) | 1,466.58 | <0.01 | 98.0% | |||
| Nucleic acid testing | 8 | 1,768 | 136 | 9.74% (5.59–14.79) | 56.37 | <0.01 | 87.6% | |||
| Serological testing | 7 | 2,070 | 433 | 15.94% (7.94–25.91) | 143.73 | <0.01 | 95.8% | |||
| Sex | 0.0447 | 0.058 (0.001–0.115) | ||||||||
| Male | 3 | 2,654 | 593 | 21.38% (17.11–26.00) | 15.21 | <0.01 | 86.9% | |||
| Female | 3 | 3,328 | 574 | 17.07% (15.34–18.87) | 3.59 | 0.17 | 44.3% | |||
| Sample | 0.0065 | 0.121 (0.034–0.207) | ||||||||
| Serum | 8 | 2,470 | 478 | 15.30% (8.34–23.79) | 162.48 | <0.01 | 95.7% | |||
| Kidney | 40 | 51,813 | 5,166 | 7.97% (6.21–9.91) | 1,750.52 | 0 | 97.8% | |||
| Season | 0.4578 | 0.057 (−0.094–0.209) | ||||||||
| Spring | 2 | 123 | 7 | 5.39% (1.82–10.38) | 0.82 | 0.37 | 0.0% | |||
| Summer | 2 | 385 | 32 | 8.28% (5.69–11.29) | 0.02 | 0.90 | 0.0% | |||
| Autumn | 7 | 4,237 | 340 | 10.76% (5.45–17.50) | 140.80 | <0.01 | 95.7% | |||
| Study quality | 0.3729 | 0.036 (−0.044–0.116) | ||||||||
| Medium | 9 | 28,762 | 3,615 | 10.58% (6.95–14.85) | 473.25 | <0.01 | 98.3% | |||
| High | 37 | 25,289 | 2,002 | 8.27% (6.25–10.54) | 1,119.27 | <0.01 | 96.8% | |||
| Total | 46 | 54,051 | 5,617 | 8.70% (6.93–10.64) | 0.01 | 0 | 98.0% | |||
P < 0.05.
CI, confidence interval.
χ2 and I2, two heterogeneity evaluation indicators, heterogeneity was predicted using I2 and Cochrane Q statistics (expressed as χ2 and P-values), with an I2 value of 25% corresponding to low heterogeneity, 50% to moderate heterogeneity and 75% to high heterogeneity.
Subgroup analysis of geographical factors.
|
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||||
| Latitude | 0.360 | 0.049 (−0.055 to 0.153) | ||||||||
| 21–25° | 7 | 4276 | 572 | 10.91% (6.02–16.94) | 139.95 | <0.01 | 95.7% | |||
| 26–30° | 25 | 14,784 | 1,822 | 8.68% (6.03–11.75) | 822.51 | <0.01 | 97.1% | |||
| 31–35° | 6 | 2,372 | 184 | 6.96% (2.96–12.44) | 102.17 | <0.01 | 95.1% | |||
| Longitude | 0.049 | 0.088 (0.001 to 0.175) | ||||||||
| 100–110° | 9 | 4612 | 283 | 5.33% (2.54–8.97) | 117.78 | <0.01 | 93.2% | |||
| 111–121° | 27 | 16,820 | 2,295 | 10.45% (7.91–13.30) | 776.07 | <0.01 | 96.6% | |||
| Altitude | 0.307 | 0.041 (−0.038 to 0.119) | ||||||||
| 0–100 m | 22 | 12,901 | 1,830 | 10.01% (7.11–13.33) | 665.57 | <0.01 | 96.8% | |||
| 101–201 m | 15 | 8,531 | 754 | 7.48% (4.70–10.80) | 317.21 | <0.01 | 95.6% | |||
| Precipitation | 0.336 | 0.061 (−0.063 to 0.184) | ||||||||
| 500–1500 mm | 20 | 11,831 | 1,301 | 7.36% (4.57–10.70) | 646.47 | <0.01 | 97.1% | |||
| 1501–2500 mm | 5 | 5,173 | 613 | 11.14% (5.38–18.62) | 211.06 | <0.01 | 98.1% | |||
| Humidity | 0.736 | 0.023 (−0.109 to 0.155) | ||||||||
| 60–70% | 4 | 895 | 57 | 6.99% (2.13–14.14) | 28.61 | <0.01 | 89.5% | |||
| 71–81% | 22 | 16,109 | 1,857 | 8.27% (5.62–11.36) | 809.72 | <0.01 | 97.42% | |||
| Mean temperature | 0.0042 | 0.279 (0.088 to 0.469) | ||||||||
| 10–15 | 4 | 1,247 | 49 | 2.61% (0.57–5.88) | 22.34 | <0.01 | 86.6% | |||
| 16–21 | 20 | 15,016 | 1,685 | 8.54% (5.9–11.59) | 666.97 | <0.01 | 97.2% | |||
| 22–27 | 2 | 741 | 180 | 24.44% (17.93–31.56) | 1.18 | 0.28 | 15.6% | |||
| Topography | 0.006 | −0.1616 (−0.2764 to −0.0468) | ||||||||
| Mountainous | 4 | 1,963 | 205 | 10.11% (4.08–18.36) | 65.98 | <0.01 | 95.5% | |||
| Hills | 5 | 1,012 | 35 | 2.98% (1.75–4.50) | 5.26 | 0.26 | 24.0% | |||
| Plain | 7 | 2,964 | 244 | 9.62% (4.55–16.28) | 147.75 | <0.01 | 95.9% | |||
| Basin | 6 | 1,738 | 231 | 12.72% (6.82–20.02) | 73.65 | <0.01 | 93.2% | |||
P < 0.05.
CI, confidence interval.
χ2 and I2, two heterogeneity evaluation indicators, heterogeneity was predicted using I2 and Cochrane Q statistics (expressed as χ2 and P values), with an I2 value of 25% corresponding to low heterogeneity, 50% to moderate heterogeneity and 75% to high heterogeneity.